Richard Eastell

52PUBLICATIONS
147CO-AUTHORS
BiomechanicsPharmaceutical delivery technologiesGeriatrics and gerontologyMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Jul 14, 2026
Imminent fracture risk: contributing mechanisms, risk assessment and implications for treatment.

|Jun 18, 2026
An index of net bone formation relative to resorption is associated with incident fracture during the menopause transition and postmenopause.

|May 11, 2026
Efficacy, pharmacodynamics, pharmacokinetics, safety, and immunogenicity of Bmab 1000 vs reference denosumab: 78-wk results from a randomized, double-blind, multicenter, parallel-arm Phase 3 trial (DEVOTE) in women with postmenopausal osteoporosis.

|Apr 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Ari Zimran, Jaco Botha, Richard Eastell

|Apr 11, 2026
Monte Carlo Resampling Validates Use of Bone Mineral Density Change as Surrogate to Replace Fracture in Future Randomized Trials of Osteoporosis Treatments: Results From SABER.

Suzanne M Dufault, Austin R Thompson, Li-Yung Lui

|Mar 04, 2026
Growth differentiation factor 15 and the risk of hip fracture in older adults.

Lorenza Mattia, Sheena Patel, Katey Webber

Pageof 9

Frequent Collaborators

13 joint publications

Tatiane Vilaca

10 joint publications

Marian Schini

9 joint publications

Fatma Gossiel

6 joint publications

Austin Thompson